Why Is Psyence Biomedical (PBM) Stock Up 90% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

With Psyence Biomedical moving into a Phase 2B trial, the credibility boost for its psychedelics-based drug lifted PBM stock.

The post Why Is Psyence Biomedical (PBM) Stock Up 90% Today? appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.